Transplant and Atrial fibrillation/flutter

Summary:

Atrial fibrillation/flutter is found among people with Transplant, especially for people who are male, 60+ old.

The study analyzes which people have Atrial fibrillation/flutter with Transplant. It is created by eHealthMe based on reports of 87 people who have Transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Transplant?

Transplant is found to be associated with 118 drugs and 203 conditions by eHealthMe. Check the latest studies of Transplant.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,364 drugs and 3,841 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 19, 2026

87 people who have Transplant and Atrial Fibrillation/Flutter are studied.

Would you have Atrial fibrillation/flutter when you have Transplant?

Gender of people who have Transplant and experienced Atrial Fibrillation/Flutter *:

female: 12.2 %
male: 87.8 %

Age of people who have Transplant and experienced Atrial Fibrillation/Flutter *:

Common co-existing conditions for these people *:

Prostate Infection: 46 people, 52.87%
High Blood Cholesterol: 43 people, 49.43%
Fluid Retention (an abnormal accumulation of fluid in the blood): 43 people, 49.43%
Cardiac Disorder: 43 people, 49.43%
Abdominal Discomfort: 41 people, 47.13%
Blood Pressure Abnormal: 41 people, 47.13%
High Blood Pressure: 17 people, 19.54%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 15 people, 17.24%
Nausea And Vomiting: 2 people, 2.30%
Multiple Myeloma (cancer of the plasma cells): 2 people, 2.30%

Common drugs taken by these people *:

Prograf: 53 people, 60.92%
Tacrolimus: 48 people, 55.17%
Sodium Bicarbonate: 47 people, 54.02%
Carvedilol: 47 people, 54.02%
Furosemide: 47 people, 54.02%
Torsemide: 47 people, 54.02%
Myfortic: 46 people, 52.87%
Candesartan Cilexetil: 45 people, 51.72%
Hygroton: 45 people, 51.72%
Aranesp: 44 people, 50.57%

Common symptoms for these people *:

Hyperkalemia (damage to or disease of the kidney): 48 people, 55.17%
Hepatic Steatosis (fatty liver disease): 47 people, 54.02%
Dizziness: 47 people, 54.02%
Rectal Prolapse (falling of rectum from normal place): 47 people, 54.02%
Bradycardia (abnormally slow heart action): 47 people, 54.02%
C-Reactive Protein Increased: 47 people, 54.02%
Carotid Arteriosclerosis (plaque deposition in artery): 47 people, 54.02%
Oedema Peripheral (superficial swelling): 47 people, 54.02%
Chronic Kidney Disease: 47 people, 54.02%
Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 47 people, 54.02%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atrial fibrillation/flutter and Transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.